Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Li, Shanshan  [Clear All Filters]
Journal Article
Zou Y, Li S, Chen W, Xu J. Urine-derived stem cell therapy for diabetes mellitus and its complications: progress and challenges. Endocrine. 2023.
Chen X, Liu X, He H, Guo X, Li S, Huang Y, Wang X, She H. Stem cell factor protects against chronic ischemic retinal injury by modulating on neurovascular unit. Biomed Pharmacother. 2024;173:116318.
Ma R, Zhou X, Zhai X, Wang C, Hu R, Chen Y, Shi L, Fang X, Liao Y, Ma L, et al. Single-cell RNA sequencing reveals immune cell dysfunction in the peripheral blood of patients with highly aggressive gastric cancer. Cell Prolif. 2024:e13591.
Yang Y, Song L, Huang X, Feng Y, Zhang Y, Liu Y, Li S, Zhan Z, Zheng L, Feng H, et al. PRPS1-mediated purine biosynthesis is critical for pluripotent stem cell survival and stemness. Aging (Albany NY). 2021;12.
Li S, Gu J, Nan W, Zhang N, Qin L, Su M, Jia M. Procalcitonin and C-reactive protein predict infection in hematopoietic stem cell transplantation patients. Leuk Res. 2021;105:106574.
Li S, Xiao Y, Jia M. Prior cytomegalovirus reactivation may lead to worse bacterial bloodstream infection outcomes in HSCT patients. Transpl Immunol. 2024:102038.
Cromwell EA, Osborne JCP, Unnasch TR, Basáñez M-G, Gass KM, Barbre KA, Hill E, Johnson KB, Donkers KM, Shirude S, et al. Predicting the environmental suitability for onchocerciasis in Africa as an aid to elimination planning. PLoS Negl Trop Dis. 2021;15(7):e0008824.
Li T, Zhang Y, Li Y, Wang X, Bao W, Huang J, Ma Y, Li S, Wang S, Yang Y, et al. Modeling leukemia with pediatric acute leukemia patient-derived iPSCs. Stem Cell Res. 2021;54:102404.
Luo F, Zhang M, Sun B, Xu C, Yang Y, Zhang Y, Li S, Chen G, Chen C, Li Y, et al. LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1/PLK3/HIF1α signaling. Mol Cancer. 2024;23(1):60.
Li S, Feng T, Zhang Y, Shi Q, Wang W, Ren J, Shen G, Gu H, Luo C, Li Y. Lianhua Qingwen protects LPS-induced acute lung injury by promoting M2 macrophage infiltration. J Ethnopharmacol. 2023:117467.
Wang W, Li X, Qin X, Miao Y, Zhang Y, Li S, Yao R, Yang Y, Yu L, Zhu H, et al. Germline Neurofibromin 1 mutation enhances the anti-tumour immune response and decreases juvenile myelomonocytic leukaemia tumourigenicity. Br J Haematol. 2023.
Li Y, Guo R, Wang L, Li S, Zhu Z, Tu P. G-CSF administration results in thrombocytopenia by inhibiting differentiation of hematopoietic progenitors into megakaryocytes. Biochem Pharmacol. 2019:113624.
Li S, Chen K, Huang C, Zhang N, Jiang H, Jiang S. First report of successful treatment for hemoglobin Bristol-Alesha by hemopoietic stem cell transplantation. Ann Hematol. 2021.
Li M, Jia J, Li S, Cui B, Huang J, Guo Z, Ma K, Wang L, Cui C. Exosomes derived from tendon stem cells promote cell proliferation and migration through the TGF β signal pathway. Biochem Biophys Res Commun. 2020;536:88-94.
Gao W, Wang X, Si Y, Pang J, Liu H, Li S, Ding Q, Wang Y. Exosome Derived from ADSCs Attenuates Ultraviolet B-mediated Photoaging in Human Dermal Fibroblasts. Photochem Photobiol. 2020.
Hu J, Zhao J, Wang C, Jia M, Su M, Li S. Epstein-Barr virus reactivation correlates with worse outcomes for patients exposed to hepatitis B virus after haploidentical hematopoietic stem cell transplantation. Ann Hematol. 2023.
Liu H, Zhou R, Li S, Dong J, Fang Y, Luo Y, Su H, Lai B, Liang L, Zhang D, et al. Epigenetic repression of by lysine-specific demethylase 1 is essential for murine heart development. iScience. 2024;27(1):108722.
Liu S, Zhang T, Li S, Wu Q, Wang K, Xu X, Lu MZ, Shao R, Zhao W, Liu H. Biomimetic Nanobomb for Synergistic Therapy with Inhibition of Cancer Stem Cells. Small. 2023:e2206503.
Xia X, Sui Y, Zhou J, Li S, Ma X, Jiang J, Yan Y. Augmenting mesenchymal stem cell therapy for osteoarthritis via inflammatory priming: a comparative study on mesenchymal stem cells derived from various perinatal tissue sources. Front Cell Dev Biol. 2023;11:1279574.
Li S, Zhang L, Li M, Huang J, Cui B, Jia J, Guo Z, Ma K, Cui C. Anti-CD19 mAb modified mesoporous titanium dioxide as exclusively targeting vector for efficient B-lymphoblastic leukemia therapy. J Pharm Sci. 2021.
Xiao H, Wang S, Tang Y, Li S, Jiang Y, Yang Y, Zhang Y, Han Y, Wu X, Zheng L, et al. Absence of terminal deoxynucleotidyl transferase expression in T-ALL/LBL accumulates chromosomal abnormalities to induce drug resistance. Int J Cancer. 2023.